A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris® ) in healthy male subjects. - Chow V; Pan J; Chien D; Mytych DT; Hanes V (European journal of haematology, 2020)